Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001019231-24-000036·Rein Therapeutics, Inc.
Schedule 13G ownership disclosure
REIN THERAPEUTICS INC
Common Stock, par value $0.001 per share · CUSIP: 00887A204
Event date: 2024-11-04
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
Shares: 960,665.00 · Class: 4.4%
- The Board of Regents of the University of Texas System
Shares: 960,665.00 · Class: 4.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001019231-24-000036
- Form type
- SCHEDULE 13G/A
- Filer
- Rein Therapeutics, Inc.
- CIK
- CIK 1420565
- Filed
- Nov 05, 2024
- Reporting period
- Nov 04, 2024
- Description
- Schedule 13G beneficial ownership